Edwards Lifesciences
603 hedge funds and large institutions have $16.9B invested in Edwards Lifesciences in 2015 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 173 increasing their positions, 245 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11% less funds holding in top 10
Funds holding in top 10: 18 → 16 (-2)
29% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 245
237.84% less ownership
Funds ownership: 492.56% → 254.71% (-238%)
Holders
603
Holding in Top 10
16
Calls
$89.6M
Puts
$49.8M
Top Buyers
| 1 | +$726M | |
| 2 | +$653M | |
| 3 | +$302M | |
| 4 |
ACM
Americafirst Capital Management
Roseville,
California
|
+$144M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$92.6M |
Top Sellers
| 1 | -$315M | |
| 2 | -$141M | |
| 3 | -$137M | |
| 4 |
HM
HealthCor Management
New York
|
-$115M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$86.8M |